Literature DB >> 34363772

Performance of saliva and mid-turbinate swabs for detection of the beta variant in South Africa.

Chun Yat Chu1, Gert Marais2, Christoffel Opperman2, Deelan Doolabh2, Arash Iranzadeh2, Carisa Marais2, Helen Cox2, Carolyn Williamson2, Diana Hardie2, Adrian Brink2.   

Abstract

Entities:  

Year:  2021        PMID： 34363772     DOI： 10.1016/S1473-3099(21)00405-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Rapid antigen testing by community health workers for detection of SARS-CoV-2 in Dhaka, Bangladesh: a cross-sectional study.

Authors:  Ayesha Sania; Ahmed Nawsher Alam; A S M Alamgir; Joanna Andrecka; Eric Brum; Fergus Chadwick; Tasnuva Chowdhury; Zakiul Hasan; Davina L Hill; Farzana Khan; Mikolaj Kundegorski; Seonjoo Lee; Mahbubur Rahman; Yael K Rayport; Tahmina Shirin; Motahara Tasneem; Katie Hampson
Journal:  BMJ Open       Date:  2022-06-01       Impact factor: 3.006

2.  Comparison of Saliva and Midturbinate Swabs for Detection of SARS-CoV-2.

Authors:  Jianyu Lai; Jennifer German; Filbert Hong; S-H Sheldon Tai; Kathleen M McPhaul; Donald K Milton
Journal:  Microbiol Spectr       Date:  2022-03-21

3.  Saliva as alternative to naso-oropharyngeal swab for SARS-CoV-2 detection by RT-qPCR: a multicenter cross-sectional diagnostic validation study.

Authors:  Michael L Tee; Aedrian A Abrilla; Cherica A Tee; Leslie Michelle M Dalmacio; Vivencio Jose P Villaflor; Al-Zamzam A Abubakar; Pedrito Y Tagayuna; Sheldon Steven C Aquino; Vicente Aaron L Bernardo; Ronald R Matias
Journal:  Sci Rep       Date:  2022-07-23       Impact factor: 4.996

4.  Use of saliva and RT-PCR screening for SARS-CoV-2 variants of concern: Surveillance and monitoring.

Authors:  Rodrigo Melim Zerbinati; Michelle Palmieri; Gabriela Schwab; Alvina Clara Felix; Herculano Martinho; Simone Giannecchini; Kelvin Kai-Wang To; Jose Angelo Lauletta Lindoso; Camila Malta Romano; Paulo Henrique Braz-Silva
Journal:  J Med Virol       Date:  2022-05-16       Impact factor: 20.693
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.